Melatonin alleviates oxidative stress-induced injury to nucleus pulposus-derived mesenchymal stem cells through

Ze-Nan Huang1,2, Ze-Yu Wang3, Xiao-Fei Cheng4

  • 1Department of Orthopedics, Shandong First Medical University & Shandong Academy of Medical Science, Shandong, 200072, China.

PubMed
Abstract

Insights

Melatonin protects nucleus pulposus mesenchymal stem cells from oxidative stress and apoptosis by activating the PI3K/Akt pathway. This finding offers a new therapeutic strategy for intervertebral disc degeneration.

Area of Science:

  • Biomedical Sciences
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Intervertebral disc degeneration (IVDD) involves oxidative stress and apoptosis of nucleus pulposus mesenchymal stem cells (NPMSCs).
  • Understanding protective mechanisms against IVDD is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the protective mechanism of melatonin against hydrogen peroxide (H₂O₂)-induced oxidative stress and apoptosis in NPMSCs.
  • To explore the role of the PI3K/Akt signaling pathway in melatonin's protective effects.

Main Methods:

  • Cell Counting Kit-8 assay for cytotoxicity and protective effects.
  • Detection of reactive oxygen species (ROS), mitochondrial membrane potential (MMP), and apoptosis (TUNEL, Annexin V/PI).
  • Analysis of apoptosis-related proteins, PI3K/Akt pathway proteins, and extracellular matrix (ECM) components via molecular techniques. In vivo evaluation using X-ray, MRI, and histology.

Main Results:

  • Melatonin (0-10 μM) demonstrated significant protective effects against H₂O₂-induced NPMSC damage, including mitochondrial dysfunction and apoptosis.
  • Melatonin treatment activated the PI3K/Akt pathway, which was crucial for its protective effects, as evidenced by PI3K-IN-1 inhibition.
  • In vivo studies showed melatonin partially mitigated intervertebral disc degeneration.

Conclusions:

  • Melatonin effectively alleviates oxidative stress-induced apoptosis and mitochondrial dysfunction in NPMSCs by activating the PI3K/Akt pathway.
  • Melatonin presents a promising therapeutic candidate for preventing and treating intervertebral disc degeneration.